Driven by growth across the board, including in its semiconductor business, German science and technology company Merck ...

Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug ...

Germany's Merck KGaA expects annual sales to be at the lower half of its outlook range after third-quarter sales missed expectations. The life-sciences and chemical group said Thursday that it now ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

Notably, the study also showed that treatment with pimicotinib provided statistically significant and clinically meaningful improvements in secondary endpoints associated with important patient ...

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...